Literature DB >> 12838201

Age of onset in hereditary lymphedema.

Kara L Levinson1, Eleanor Feingold, Robert E Ferrell, Thomas W Glover, Elias I Traboulsi, David N Finegold.   

Abstract

OBJECTIVE: To characterize age of onset patterns and penetrance in hereditary lymphedema, including differences caused by sex and genetic heterogeneity. STUDY
DESIGN: Kaplan-Meier analysis of three family cohorts with autosomal dominant lymphedema: (1) five families with unique mutations in FLT4, (2) 16 families with unique mutations in FOXC2, and (3) 77 families with no mutations yet identified in any gene (the heterogeneous group).
RESULTS: Age of onset was typically congenital among FLT4 mutation families and pubertal among FOXC2 mutation families, with similar male and female penetrance in both groups. Age of onset was highly variable in the families with no identified mutation, with substantially higher penetrance among female patients than male patients. In addition, male patients and female patients in the heterogeneous group had very different overall age of onset profiles.
CONCLUSIONS: The two genes identified to date that cause hereditary lymphedema have equal male and female effects, but each displays a different pattern of onset age and penetrance. The heterogeneous group represents a genetically heterogeneous population and has phenotypic overlaps with the FLT4 and FOXC2 mutation families.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838201     DOI: 10.1067/mpd.2003.235

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Soft-tissue malignant fibrous histiocytoma (high-grade undifferentiated pleomorphic sarcoma) arising in a desmoid tumor in a patient with Milroy's disease.

Authors:  Mary I O'Connor; Mark J Kransdorf; David M Menke
Journal:  Skeletal Radiol       Date:  2006-01-25       Impact factor: 2.199

Review 2.  Milroy disease and the VEGFR-3 mutation phenotype.

Authors:  G Brice; A H Child; A Evans; R Bell; S Mansour; K Burnand; M Sarfarazi; S Jeffery; P Mortimer
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

3.  Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.

Authors:  Ronen Spiegel; Arash Ghalamkarpour; Etty Daniel-Spiegel; Miikka Vikkula; Stavit A Shalev
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

4.  Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.

Authors:  F C Connell; P Ostergaard; C Carver; G Brice; N Williams; S Mansour; P S Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2008-11-12       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.